Table 1.
Tissue concentrations of dopamine and its metabolites in the striatum
| Group | n | Region | DA, % control | DA, ng/mg | HVA, ng/mg | DOPAC, ng/mg | 3-MT, ng/mg |
|---|---|---|---|---|---|---|---|
| vrDD-DL | 4 | Dorsal | 32.3 | 40.33 ± 5.67 | 3.76 ± 0.48 | 2.58 ± 0.69 | 7.52 ± 1.08 |
| Sham | 4 | Dorsal | 100 | 124.85 ± 16.2 | 10.15 ± 1.01 | 8.53 ± 0.77 | 11.81 ± 0.96 |
| vrDD-DL | 4 | Ventral | 2.03 | 1.43 ± 0.29 | 1.30 ± 0.16 | 0.37 ± 0.02 | n.d. |
| Sham | 4 | Ventral | 100 | 70.54 ± 14.87 | 8.81 ± 1.58 | 8.31 ± 1.28 | 7.95 ± 0.93 |
DA, dopamine; HVA, homovanillic acid; DOPAC, 3.4-dihydroxyphenylacetic acid; 3-MT, 3-methoxytyramine content. Data are presented as mean ± SEM (n.d. = none detected).